Differential effects of Paclitaxel on dendritic cell function
Open Access
- 19 March 2010
- journal article
- Published by Springer Science and Business Media LLC in BMC Immunology
- Vol. 11 (1), 14
- https://doi.org/10.1186/1471-2172-11-14
Abstract
Background: The potential utility of dendritic cells (DC) as cancer vaccines has been established in early trials in human cancers. The concomitant administration of cytotoxic agents and DC vaccines has been previously avoided due to potential immune suppression by chemotherapeutics. Recent studies show that common chemotherapy agents positively influence adaptive and innate anti-tumour immune responses.Results: We investigated the effects of paclitaxel on human DC biologyin vitro. DCs appear to sustain a significant level of resistance to paclitaxel and maintain normal viability at concentrations of up to 100 μmol. In some cases this resistance against paclitaxel is significantly better than the level seen in tumour cell lines. Paclitaxel exposure led to a dose dependent increase in HLA class II expression equivalent to exposure to lipopolysaccharide (LPS), and a corresponding increase in proliferation of allogeneic T cells at the clinically relevant doses of paclitaxel. Increase in HLA-Class II expression induced by paclitaxel was not blocked by anti TLR-4 antibody. However, paclitaxel exposure reduced the endocytic capacity of DC but reduced the expression of key pro-inflammatory cytokines such as IL-12 and TNFα. Key morphological changes occurred when immature DC were cultured with 100 μmol paclitaxel. They became small rounded cells with stable microtubules, whereas there were little effects on LPS-matured DC.Conclusions: The effect of paclitaxel on human monocyte derived DC is complex, but in the clinical context of patients receiving preloaded and matured DC vaccines, its immunostimulatory potential and resistance to direct cytotoxicity by paclitaxel would indicate potential advantages to co-administration with vaccines.Keywords
This publication has 39 references indexed in Scilit:
- The role of Bcl-xL and nuclear factor-κB in the effect of taxol on the viability of dendritic cellsJournal of Veterinary Science, 2009
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Molecular basis for lipopolysaccharide mimetic action of Taxol™ and flavolipinInnate Immunity, 2003
- Molecular basis for lipopolysaccharide mimetic action of Taxol™ and flavolipinInnate Immunity, 2003
- Influence of drug‐induced apoptotic death on processing and presentation of tumor antigens by dendritic cellsInternational Journal of Cancer, 2003
- MyD88 is involved in the signalling pathway for Taxol-induced apoptosis and TNF-α expression in human myelomonocytic cellsBritish Journal of Haematology, 2002
- The role of MyD88 and TLR4 in the LPS-mimetic activity of TaxolEuropean Journal of Immunology, 2001
- The Will to RememberJournal of Homosexuality, 1998
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Preclinical screening and analysis of the immunotoxic and immunomodulatory activity using a multiple immunoassay (MIA) in miceInternational Journal of Immunopharmacology, 1990